Effective Vaccine Against Breast Cancer Metastases
Author Information
Author(s): Kim S H, Castro F, Gonzalez D, Maciag P C, Paterson Y, Gravekamp C
Primary Institution: California Pacific Medical Center Research Institute
Hypothesis
Can the delivery of the Mage-b vaccine using recombinant Listeria monocytogenes enhance its efficacy against breast cancer metastases?
Conclusion
The LM-LLO-Mage-b/2nd vaccine significantly reduced the number of breast cancer metastases by 96% compared to the saline group.
Supporting Evidence
- Vaccination with LM-LLO-Mage-b/2nd reduced metastases by 96% compared to saline.
- Strong Mage-b-specific CD8 T-cell responses were observed in vaccinated mice.
- The vaccine did not affect the growth of primary tumors.
Takeaway
A new vaccine helped mice fight off breast cancer spread by making their immune system stronger.
Methodology
Mice were vaccinated with different strains of the Mage-b vaccine and then injected with breast cancer cells to test the vaccine's effectiveness against metastases.
Limitations
The vaccine did not affect the growth of primary tumors, indicating a limitation in its application.
Participant Demographics
Normal female Balb/c mice, 3 months old.
Statistical Information
P-Value
0.0005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website